Development of pulmonary and cardiac sarcoidosis during etanercept therapy-Reference-Cited by-同舟云学术

Development of pulmonary and cardiac sarcoidosis during etanercept therapy

Author:

Miyagi Rumiko¹,Ideguchi Haruko¹,Soga Takayoshi¹²,Yamakawa Yasushi³,Otsuki Hisao⁴⁵,Niino Hitoshi⁶,Shiina Takeki⁷,Ueda Atsuhisa⁸,Ishigatsubo Yoshiaki⁸

Affiliation:

1. Department of Rheumatology; National Hospital Organization Yokohama Medical Center; Yokohama Japan

2. Department of Rheumatology; Japanese Red Cross Shizuoka Hospital; Shizuoka Japan

3. Department of Respiratory Medicine; National Hospital Organization Yokohama Medical Center; Yokohama Japan

4. Department of Cardiology; National Hospital Organization Yokohama Medical Center; Yokohama Japan

5. Department of Cardiology; Saiseikai Kurihashi Hospital; Kuki Japan

6. Department of Pathology; National Hospital Organization Yokohama Medical Center; Yokohama Japan

7. Department of Radiology; National Hospital Organization Yokohama Medical Center; Yokohama Japan

8. Department of Internal Medicine and Clinical Immunology; Yokohama City University Graduate School of Medicine; Yokohama Japan

Publisher

Wiley

Subject

Rheumatology

Link

Reference11 articles.

3. National survey on status of steroid therapy for cardiac sarcoidosis in Japan;Hiramitsu;Sarcoidosis Vasc Diffuse Lung Dis,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献